Novel Kappa Opioid Receptor Agonist as Improved PET Radiotracer: Development and in Vivo Evaluation.

Abstract

The kappa opioid receptor (KOR) is involved in depression, alcoholism, and drug abuse. The current agonist radiotracer 11C-GR103545 is not ideal for imaging KOR due to its slow tissue kinetics in human. The aim of our project was to develop novel KOR agonist radiotracers with improved imaging properties. A novel compound FEKAP ((( R))-4-(2-(3,4-dichlorophenyl)acetyl)-3-((ethyl(2-fluoroethyl)amino)methyl) piperazine-1-carboxylate) was designed, synthesized, and assayed for in vitro binding affinities. It was then radiolabeled and evaluated in rhesus monkeys. Baseline and blocking scans were conducted on a Focus-220 scanner to assess binding specificity and selectivity. Metabolite-corrected arterial activities over time were measured and used as input functions to analyze the brain regional time-activity curves and derive kinetic and binding parameters with kinetic modeling. FEKAP displayed high KOR binding affinity ( Ki = 0.43 nM) and selectivity (17-fold over mu opioid receptor and 323-fold over delta opioid receptor) in vitro. 11C-FEKAP was prepared in high molar activity (mean of 718 GBq/μmol, n = 19) and >99% radiochemical purity. In monkeys, 11C-FEKAP metabolized fairly fast, with ∼31% of intact parent fraction at 30 min post-injection. In the brain, it exhibited fast and reversible kinetics with good uptake. Pretreatment with the nonselective opioid receptor antagonist naloxone (1 mg/kg) decreased uptake in high binding regions to the level in the cerebellum, and the selective KOR antagonist LY2456302 (0.02 and 0.1 mg/kg) reduced 11C-FEKAP specific binding in a dose-dependent manner. As a measure of specific binding signals, the mean binding potential ( BPND) values of 11C-FEKAP derived from the multilinear analysis-1 (MA1) method were greater than 0.5 for all regions, except for the thalamus. The novel KOR agonist tracer 11C-FEKAP demonstrated binding specificity and selectivity in vivo and exhibited attractive properties of fast tissue kinetics and high specific binding.

• Authors: Songye Li, Ming-Qiang Zheng, Mika Naganawa, Hong Gao, Richard Pracitto, Anupama Shirali, Shu-Fei Lin, Jo-Ku Teng, Jim Ropchan, Yiyun Huang
• Journal: Molecular pharmaceutics (Mol Pharm) Vol. 16 Issue 4 Pg. 1523-1531 (04 01 2019) ISSN: 1543-8392 [Electronic] United States
• PMID: 30726092 (Publication Type: Evaluation Study, Journal Article, Research Support, N.I.H., Extramural)

Chemical References

• Carbon Radioisotopes
• FEKAP
• Piperazines
• Radioactive Tracers
• Radiopharmaceuticals
• Receptors, Opioid, kappa

Topics

• Animals
• Brain (diagnostic imaging, drug effects, metabolism)
• Carbon Radioisotopes (pharmacokinetics)
• Macaca mulatta
• Piperazines (chemical synthesis, pharmacology)
• Positron-Emission Tomography (methods)
• Radioactive Tracers
• Radiopharmaceuticals (chemical synthesis, pharmacology)
• Receptors, Opioid, kappa (agonists)
• Tissue Distribution